# Use of Teicoplanin on a Three-weekly Administration in the Infectious Diseases Unit

> **NCT06426212** · — · RECRUITING · sponsor: **Azienda Ospedaliera di Lecco** · enrollment: 40 (estimated)

## Conditions studied

- Comparison of Teicoplanin Used Three Times a Week in DSIs vs NDISs

## Interventions

- **DRUG:** Use of teicoplanin three times a week

## Key facts

- **NCT ID:** NCT06426212
- **Lead sponsor:** Azienda Ospedaliera di Lecco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-07
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06426212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06426212, "Use of Teicoplanin on a Three-weekly Administration in the Infectious Diseases Unit". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06426212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*